Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...

In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...

The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a ...

Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...

Delaware's Supreme Court sides with drugmakers including GSK (GSK) and Pfizer (PFE), rejecting expert testimony linking ...

Zantac and ranitidine are routinely used by millions of heartburn sufferers. So how did the drug become a cancer risk? Hotspots ranked Start the day smarter ☀️ Funniest cap messages Get the ...

CVS and Walgreens quit selling heartburn drug Zantac and generic ranitidine products during an ongoing FDA investigation into possible cancer risks. $3,500 iPhone possible? What to know 📋 How ...

Zantac, and all ranitidine products, should be removed from shelves, as the FDA cites carcinogen NDMA concerns. The U.S. Food and Drug Administration Wednesday said Zantac should be removed from ...

Aurobindo Pharma USA is the latest company to issue a voluntary recall on ranitidine products, joining several other companies in pulling batches of the drug over concerns regarding the impurity N ...

Since the FDA first warned that ranitidine products may contain a potentially cancer-causing impurity, known as N-nitrosodimethylamine, numerous drugmakers have recalled their ranitidine products ...

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on ...

Zantac, and all ranitidine products, should be removed from shelves, as the FDA cites carcinogen NDMA concerns. The U.S. Food and Drug Administration Wednesday said Zantac should be removed from ...